Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

LAVA Therapeutics N.V.
Sponsor

LAVA Therapeutics N.V.

The Netherlands Yalelaan 62, 3584 CM Utrecht, The Netherlands

About the sponsor

Clinical research in metastatic castration-resistant prostate cancer focuses on therapy-refractory disease and PSMA-targeted immunotherapy approaches.

  • PSMA-targeting bispecific γδ-T cell engagers
  • Combination immunotherapy
  • Metastatic castration-resistant prostate cancer

Interest extends to both measurable and non-measurable disease settings, with attention to antitumor activity and immune-based treatment strategies.

About Specializations

LAVA Therapeutics N.V. runs clinical trials in conditions such as Prostate cancer metastatic, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Prostate cancer metastatic

Not recruiting

Study on LAVA-1207 and Pembrolizumab for Patients with Advanced Prostate Cancer Resistant to Treatment

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:LAVA Therapeutics N.V.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.